Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.2067
S.2067: Prostate Cancer Misdiagnosis Elimination Act of 2017
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced Nov. 2, 2017
- Latest Major Action Nov. 2, 2017
Bill Sponsor
Bill Version
- Introduced in Senate - Nov. 2, 2017
Bill Summary
Prostate Cancer Misdiagnosis Elimination Act of 2017 This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Nov. 2, 2017 |
Read twice and referred to the Committee on Finance.
|
Nov. 2, 2017 |
Introduced in the Senate by Michael D. Crapo (R-Idaho) |